SUNNYVALE, Calif., March 5, 2015 -- Accuray Incorporated (Nasdaq: ARAY) and Christie InnoMed Inc. announced today that they have entered into sales agent agreements involving the CyberKnife® and TomoTherapy® System product portfolios in Canada. Under the terms of these agreements, Christie InnoMed
Joint Venture Uniquely Positioned to Serve World's Largest Growth Market for Radiation Oncology Systems Conference Call Today at 6:00 a.m. PT/ 9:00 a.m. ET SUNNYVALE, Calif. and TIANJIN, China , Jan. 28, 2019 /PRNewswire/ -- Accuray Asia Limited , a subsidiary of Accuray Incorporated (NASDAQ:
SUNNYVALE, Calif. , Oct. 13, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company, in partnership with C-RAD AB (NASDAQ Stockholm: CRAD B), will showcase an important new option for improving the care of people diagnosed with breast cancer during the 2022 ASTRO (
Click here for PDF version of this release Revenue, Operating Expenses, Cash Flows and Backlog Unaffected SUNNYVALE, Calif., May 14 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today issued an amended announcement of its fiscal third
With Installation of its Seventh System, HCA Expands CyberKnife Treatments into the United Kingdom SUNNYVALE, Calif ., Dec. 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 150 CyberKnife(R) Robotic Radiosurgery
SUNNYVALE, Calif. , April 12, 2017 /PRNewswire/ -- Renowned radiation oncologists, physicists, therapists and administrators from around the world joined together at the Accuray Exchange in Radiation Oncology (AERO™) Users' Summit to discuss best practices and further collaborations that will
SUNNYVALE, Calif. , Nov. 4, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the International Chamber of Commerce International Court of Arbitration (ICC) issued an interim award in an arbitration filed by Cowealth Medical Holding Co., Ltd.
Presentations Highlight the Unmatched Clinical Excellence and Broad Range of Applications for the CyberKnife® and TomoTherapy® Systems SUNNYVALE, Calif. , Nov. 8, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that studies
This Recognition of Clinical Benefits Across Europe is Supported by Five-Year Outcomes for Low-Risk Prostate Cancer Patients Treated in Five Sessions SUNNYVALE, Calif., May 11, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery,
SUNNYVALE, Calif., Sept. 23, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced details of the 2011 International Conference on TomoTherapy (ICT) , which took place September 16-17, 2011 hosted by the University of
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
